High Mark Wealth Management LLC Crispr Therapeutics Ag Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, High Mark Wealth Management LLC holds 10 shares of CRSP stock, worth $412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$412
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
57.8MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$327 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$309 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$123 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$122 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.21B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....